ascopubs.org

Concomitant chemoradiotherapy using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with advanced sino-nasal squamous cell carcinoma.

Investigating the feasibility of targeted next-generation sequencing to guide the treatment of head and neck squamous cell carcinoma. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting ...
ascopubs.org

Induction and concomitant chemoradiotherapy (CCRT) using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with stage IVB advanced head and neck cancer.

Combinatorial immune biomarkers of efficacy on buparlisib and paclitaxel in patients with SCCHN: BERIL-1 sub-analysis. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...